Poseida Therapeutics PSTX
€ 2.59
0.18%
Quartalsbericht 2024-Q3
hinzugefügt 07.11.2024
Poseida Therapeutics Bilanz 2011-2024 | PSTX
Bilanz Jährlich Poseida Therapeutics
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nettoverschuldung |
20.1 M | -17.3 M | -171 M | -51.8 M | -58.6 M | -11.3 M | -5.92 M | - | - | - | - | - | - |
Langfristige Schulden |
58.6 M | 58.2 M | 29.4 M | 29.1 M | 26.1 M | 19.1 M | 8.6 M | - | - | - | - | - | - |
Langfristiger Schuldenstrom |
5.95 M | 5.87 M | 6.34 M | 4.81 M | - | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | 79.5 M | 275 M | 109 M | 51.8 M | - | - | - | - | - | - |
Kurzfristige Verbindlichkeiten |
71.3 M | 53.9 M | 43.3 M | 30 M | - | - | - | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
170 M | 164 M | 113 M | 110 M | 297 M | 122 M | 59 M | - | - | - | - | - | - |
Aufgeschobenes Einkommen |
31 M | 19.7 M | 4.5 M | - | - | - | - | - | - | - | - | - | - |
Gewinnrücklagen |
-594 M | -471 M | -407 M | -282 M | -152 M | -65.7 M | -21.3 M | - | - | - | - | - | - |
Vermögenswerte |
274 M | 352 M | 269 M | 371 M | 147 M | 45.1 M | 25.5 M | - | - | - | - | - | - |
Zahlungsmittel |
44.5 M | 81.4 M | 206 M | 84 M | - | - | - | - | - | - | - | - | - |
Buchwert |
104 M | 188 M | 156 M | 262 M | -150 M | -76.7 M | -33.5 M | - | - | - | - | - | - |
Gesamtes Eigenkapital |
104 M | 188 M | 156 M | 262 M | -150 M | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Bilanz Vierteljährlich Poseida Therapeutics
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Langfristige Schulden |
58.9 M | 58.8 M | 58.7 M | 58.6 M | 58.5 M | 58.4 M | 58.3 M | 58.2 M | 58.2 M | 58.1 M | 58 M | 29.4 M | 29.3 M | 29.3 M | 26.2 M | 29.1 M | 29.1 M | 29.1 M | 29.1 M | 26.1 M | 26.1 M | 26.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
206 M | 238 M | 178 M | 170 M | 179 M | 146 M | 156 M | 164 M | 164 M | 140 M | 144 M | 113 M | 112 M | 113 M | 106 M | 110 M | 110 M | 110 M | 110 M | 74.3 M | 74.3 M | 74.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Aufgeschobenes Einkommen |
37.3 M | 63.3 M | 49.8 M | 31 M | 44.8 M | 20.2 M | 20.1 M | 19.7 M | 16.7 M | 1.05 M | 3.36 M | 4.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gewinnrücklagen |
-630 M | -650 M | -619 M | -594 M | -569 M | -537 M | -510 M | -471 M | -438 M | -508 M | -465 M | -407 M | -408 M | -366 M | -320 M | -282 M | -282 M | -282 M | -282 M | -152 M | -152 M | -152 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Vermögenswerte |
294 M | 299 M | 263 M | 274 M | 302 M | 281 M | 314 M | 352 M | 380 M | 205 M | 248 M | 269 M | 262 M | 299 M | 333 M | 371 M | 371 M | 371 M | 371 M | 147 M | 147 M | 147 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Zahlungsmittel |
49.3 M | 30.5 M | 53.3 M | 44.5 M | 25.5 M | 49.9 M | 40.1 M | 81.4 M | 165 M | 63 M | 183 M | 206 M | 198 M | 200 M | 170 M | 84 M | 84 M | 84 M | 84 M | 87.8 M | 87.8 M | 87.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Buchwert |
87.2 M | 60.8 M | 84.6 M | 104 M | 124 M | 135 M | 158 M | 188 M | 216 M | 65.8 M | 104 M | 156 M | 150 M | 187 M | 227 M | 262 M | 262 M | 262 M | 262 M | 72.7 M | 72.7 M | 72.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtes Eigenkapital |
87.2 M | 60.8 M | 84.6 M | 104 M | 124 M | 135 M | 158 M | 188 M | 216 M | 65.8 M | 104 M | 156 M | 150 M | 187 M | 227 M | 262 M | 262 M | 262 M | 262 M | -150 M | -150 M | -150 M | -89.6 M | -76.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung